Alzheimer's Disease Trial, Recruiting NCT05658913 Sponsor: University of Pennsylvania Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05658913
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are already enrolled in a related study called the MPC study, run at the University of Pennsylvania or Massachusetts General Hospital
  • People who have a reliable person (such as a family member or friend) who can accompany them to the PET/CT scan appointment
  • People who have had a brain MRI scan within the past 6 months that is of good enough quality for use in the study, including detailed imaging of a specific region of the brain called the medial temporal lobe

Who may not be able to join:

  • People with medical or psychiatric conditions that, in the opinion of the study investigators, could affect their safety or ability to take part
  • People whose MRI shows significant structural problems in the brain, such as a major stroke or a growth, that could interfere with the PET/CT scan results
  • People for whom the imaging procedures are not suitable or safe, as determined by an investigator or treating doctor
  • People with a history of significant ongoing alcohol or substance misuse, based on self-report
  • Women of childbearing age, based on self-report

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: David A. Wolk, University of Pennsylvania Department of Neurology at the Perelman School of Medicine

Phone: 610-299-1243

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 March 2023
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Clusters based on spatial pattern and extent of T-N Mismatch

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov